Centessa Pharmaceuticals plc (CNTA)

Exchange NASDAQ
4.6


Currency in USD (Disclaimer)
Volume:
Day's Range:

CNTA Insider Trading

Transaction Date Reporting Name Relationship Shrs. Owned Type Acq./Disp. Shrs. Transacted Price(USD) Amount(USD) SEC Filing
2022-06-17 YVER ANTOINE officer: EVP & Chairman of Development 739,697.0 S-Sale D 9,200.0 4.68 43,035.76
2022-05-18 YVER ANTOINE officer: EVP & Chairman of Development 748,897.0 S-Sale D 64,778.0 5.10 330,102.21
2022-05-17 YVER ANTOINE officer: EVP & Chairman of Development 813,675.0 S-Sale D 20,222.0 5.42 109,631.55
2022-04-01 Shahidi Javad officer: Chief Medical Officer 330,000.0 A-Award A 330,000.0 9.08 2,996,400.00
2022-03-21 Thorell Marella officer: Chief Accounting Officer 53,101.0 J-Other A 52,101.0 0.00 0.00
2022-03-21 De Rubertis Francesco director 281,162.0 J-Other A 45,054.0 0.00 0.00
2022-03-21 De Rubertis Francesco director 11,197,303 J-Other A 1,794,211.0 0.00 0.00
2022-03-21 Medicxi Ventures Management (Jersey) Ltd 10 percent owner 281,162.0 J-Other A 45,054.0 0.00 0.00
2022-03-21 Medicxi Ventures Management (Jersey) Ltd 10 percent owner 11,197,303 J-Other A 1,794,211.0 0.00 0.00
2022-02-02 SAHA SAURABH director, officer: Chief Executive Officer 28,000.0 P-Purchase A 5,000.0 9.74 48,700.00
2022-02-01 Weinhoff Gregory M officer: Chief Financial Officer 230,000.0 A-Award A 230,000.0 9.53 2,191,900.00
2022-02-01 YVER ANTOINE officer: Chief Medical Officer 200,000.0 A-Award A 200,000.0 9.53 1,906,000.00
2022-02-01 SAHA SAURABH director, officer: Chief Executive Officer 750,000.0 A-Award A 750,000.0 9.53 7,147,500.00
2022-02-01 GRAINGER DAVID J officer: Chief Innovation Officer 200,000.0 A-Award A 200,000.0 9.53 1,906,000.00
2022-02-01 Templeman Thomas officer: Chief Technology Officer 140,000.0 A-Award A 140,000.0 9.53 1,334,200.00
2022-02-01 HUSSAIN IQBAL J officer: General Counsel 160,000.0 A-Award A 160,000.0 9.53 1,524,800.00
2022-02-01 Bush Tia L officer: Chief Quality Officer 140,000.0 A-Award A 140,000.0 9.53 1,334,200.00
2022-02-01 Thorell Marella officer: Chief Accounting Officer 67,500.0 A-Award A 67,500.0 9.53 643,275.00
2022-02-01 CHAO DAVID M officer: Chief Administrative Officer 230,000.0 A-Award A 230,000.0 9.53 2,191,900.00
2022-01-28 GRAINGER DAVID J officer: Chief Innovation Officer 27,500.0 P-Purchase A 27,500.0 9.05 248,754.00
2021-12-02 De Rubertis Francesco director 93,526.0 P-Purchase A 796.0 12.82 10,204.72
2021-12-02 De Rubertis Francesco director 3,936,970.0 P-Purchase A 33,530.0 12.82 429,854.60
2021-12-02 Medicxi Ventures Management (Jersey) Ltd 10 percent owner 93,526.0 P-Purchase A 796.0 12.82 10,204.72
2021-12-02 Medicxi Ventures Management (Jersey) Ltd 10 percent owner 3,936,970.0 P-Purchase A 33,530.0 12.82 429,854.60
2021-12-01 De Rubertis Francesco director 92,730.0 P-Purchase A 1,399.0 12.62 17,655.38
2021-12-01 De Rubertis Francesco director 3,903,440.0 P-Purchase A 58,905.0 12.62 743,381.10
2021-12-01 Medicxi Ventures Management (Jersey) Ltd 10 percent owner 92,730.0 P-Purchase A 1,399.0 12.62 17,655.38
2021-12-01 Medicxi Ventures Management (Jersey) Ltd 10 percent owner 3,903,440.0 P-Purchase A 58,905.0 12.62 743,381.10
2021-11-30 De Rubertis Francesco director 91,331.0 P-Purchase A 855.0 11.62 9,935.10
2021-11-30 De Rubertis Francesco director 3,844,535.0 P-Purchase A 35,992.0 11.62 418,227.04
2021-11-30 Medicxi Ventures Management (Jersey) Ltd 10 percent owner 91,331.0 P-Purchase A 855.0 11.62 9,935.10
2021-11-30 Medicxi Ventures Management (Jersey) Ltd 10 percent owner 3,844,535.0 P-Purchase A 35,992.0 11.62 418,227.04
2021-11-29 De Rubertis Francesco director 90,476.0 P-Purchase A 1,315.0 11.70 15,385.89
2021-11-29 De Rubertis Francesco director 3,808,543.0 P-Purchase A 55,391.0 11.70 648,091.32
2021-11-29 Medicxi Ventures Management (Jersey) Ltd 10 percent owner 90,476.0 P-Purchase A 1,315.0 11.70 15,385.89
2021-11-29 Medicxi Ventures Management (Jersey) Ltd 10 percent owner 3,808,543.0 P-Purchase A 55,391.0 11.70 648,091.32
2021-11-26 De Rubertis Francesco director 89,161.0 P-Purchase A 274.0 11.34 3,105.87
2021-11-26 De Rubertis Francesco director 3,753,152.0 P-Purchase A 11,543.0 11.34 130,843.37
2021-11-26 Medicxi Ventures Management (Jersey) Ltd 10 percent owner 89,161.0 P-Purchase A 274.0 11.34 3,105.87
2021-11-26 Medicxi Ventures Management (Jersey) Ltd 10 percent owner 3,753,152.0 P-Purchase A 11,543.0 11.34 130,843.37
2021-11-18 KANTOFF AARON director 60,000.0 P-Purchase A 10,000.0 11.99 119,850.00
2021-11-16 SAHA SAURABH director, officer: Chief Executive Officer 23,000.0 P-Purchase A 23,000.0 12.28 282,472.20
2021-11-16 Bush Tia L officer: Chief Quality Officer 8,000.0 P-Purchase A 4,005.0 12.55 50,262.75
2021-11-16 Bush Tia L officer: Chief Quality Officer 3,995.0 P-Purchase A 995.0 12.10 12,039.50
2021-11-01 GRAINGER DAVID J officer: Chief Innovation Officer 175,000.0 A-Award A 175,000.0 14.01 2,451,750.00
2021-07-01 GOYAL ARJUN director 64,570.0 A-Award A 64,570.0 22.55 1,456,053.50
2021-07-01 ZBAR BRETT I W director 64,570.0 A-Award A 64,570.0 22.55 1,456,053.50
2021-06-02 Medicxi Ventures Management (Jersey) Ltd 10 percent owner 3,741,609.0 P-Purchase A 586,077.0 20.00 11,721,540.00
2021-06-02 Medicxi Ventures Management (Jersey) Ltd 10 percent owner 74,964.0 C-Conversion A 44,828.0 0.00 0.00
2021-06-02 Medicxi Ventures Management (Jersey) Ltd 10 percent owner 3,155,532.0 C-Conversion A 1,886,990.0 0.00 0.00
2021-06-02 Medicxi Ventures Management (Jersey) Ltd 10 percent owner 0.0 C-Conversion D 44,828.0 0.00 0.00
2021-06-02 Medicxi Ventures Management (Jersey) Ltd 10 percent owner 88,887.0 P-Purchase A 13,923.0 20.00 278,460.00
2021-06-02 Thorell Marella officer: Chief Accounting Officer 1,000.0 P-Purchase A 1,000.0 20.00 20,000.00
2021-06-02 Weinhoff Gregory M officer: Chief Financial Officer 319,660.0 G-Gift A 319,660.0 5.84 1,866,814.40
2021-06-02 Weinhoff Gregory M officer: Chief Financial Officer 639,321.0 G-Gift A 319,660.0 5.84 1,866,814.40
2021-06-02 Weinhoff Gregory M officer: Chief Financial Officer 958,981.0 A-Award A 958,981.0 5.84 5,600,449.04
2021-06-02 Weinhoff Gregory M officer: Chief Financial Officer 10,000.0 P-Purchase A 10,000.0 20.00 200,000.00
2021-06-02 GAP (Bermuda) LTD 10 percent owner 9,681,818.0 P-Purchase A 1,500,000.0 20.00 30,000,000.00
2021-06-02 De Rubertis Francesco director 0.0 C-Conversion D 44,828.0 0.00 0.00
2021-06-02 De Rubertis Francesco director 44,828.0 A-Award D 44,828.0 11.00 493,108.00
2021-06-02 De Rubertis Francesco director 1,886,990.0 A-Award D 1,886,990.0 11.00 20,756,890.00
2021-06-02 De Rubertis Francesco director 88,887.0 P-Purchase A 13,923.0 20.00 278,460.00
2021-06-02 De Rubertis Francesco director 3,741,609.0 P-Purchase A 586,077.0 20.00 11,721,540.00
2021-06-02 De Rubertis Francesco director 74,964.0 C-Conversion A 44,828.0 0.00 0.00
2021-06-02 De Rubertis Francesco director 3,155,532.0 C-Conversion A 1,886,990.0 0.00 0.00
2021-06-02 CHAO DAVID M officer: Chief Administrative Officer 583,728.0 A-Award A 583,728.0 9.42 5,498,717.76
2021-06-02 CHAO DAVID M officer: Chief Administrative Officer 500.0 P-Purchase A 500.0 20.00 10,000.00
2021-06-02 Bush Tia L officer: Chief Quality Officer 500,338.0 A-Award A 500,338.0 9.42 4,713,183.96
2021-06-02 Bush Tia L officer: Chief Quality Officer 3,000.0 P-Purchase A 3,000.0 20.00 60,000.00
2021-06-02 Templeman Thomas officer: Chief Technology Officer 500,338.0 A-Award A 500,338.0 9.42 4,713,183.96
2021-06-02 Templeman Thomas officer: Chief Technology Officer 250.0 P-Purchase A 250.0 20.00 5,000.00
2021-06-02 HUSSAIN IQBAL J officer: General Counsel 5,500.0 P-Purchase A 5,500.0 20.00 110,000.00
2021-06-02 HUSSAIN IQBAL J officer: General Counsel 3,000.0 P-Purchase A 3,000.0 20.00 60,000.00
2021-06-02 GOYAL ARJUN director 0.0 C-Conversion D 85,909.0 0.00 0.00
2021-06-02 GOYAL ARJUN director 85,909.0 A-Award D 85,909.0 11.00 944,999.00
2021-06-02 GOYAL ARJUN director 3,095,909.0 A-Award D 3,095,909.0 11.00 34,054,999.00
2021-06-02 GOYAL ARJUN director 106,159.0 P-Purchase A 20,250.0 20.00 405,000.00
2021-06-02 GOYAL ARJUN director 3,825,659.0 P-Purchase A 729,750.0 20.00 14,595,000.00
2021-06-02 GOYAL ARJUN director 85,909.0 C-Conversion A 85,909.0 0.00 0.00
2021-06-02 GOYAL ARJUN director 3,095,909.0 C-Conversion A 3,095,909.0 0.00 0.00
2021-05-27 YVER ANTOINE officer: Chief Medical Officer 833,897.0 A-Award A 833,897.0 0.00 0.00
2021-05-27 HUSSAIN IQBAL J officer: General Counsel 100,000.0 A-Award A 100,000.0 20.00 2,000,000.00
2021-05-27 HUSSAIN IQBAL J officer: General Counsel 166,779.0 A-Award A 166,779.0 9.42 1,571,058.18
2021-05-27 HUSSAIN IQBAL J officer: General Counsel 333,559.0 A-Award A 333,559.0 5.84 1,947,984.56
2021-05-27 Thorell Marella officer: Chief Accounting Officer 137,500.0 A-Award A 137,500.0 20.00 2,750,000.00
2021-05-27 Thorell Marella officer: Chief Accounting Officer 208,474.0 A-Award A 208,474.0 5.84 1,217,488.16
2021-05-27 Thorell Marella officer: Chief Accounting Officer 9,487.0 A-Award A 9,487.0 4.87 46,201.69
2021-05-27 Thorell Marella officer: Chief Accounting Officer 58,956.0 A-Award A 58,956.0 4.11 242,309.16
2021-05-07 Bush Tia L 500,338.0 A-Award A 500,338.0 9.42 4,713,183.96
2021-04-20 HUSSAIN IQBAL J 166,779.0 A-Award A 166,779.0 0.00 0.00
2021-04-20 CHAO DAVID M 583,728.0 A-Award A 583,728.0 9.42 5,498,717.76
2021-04-20 Templeman Thomas 500,338.0 A-Award A 500,338.0 9.42 4,713,183.96
2021-04-08 Weinhoff Gregory M 639,321.0 G-Gift D 319,660.0 0.00 0.00
2021-04-08 Weinhoff Gregory M 319,660.0 G-Gift A 319,660.0 0.00 0.00
2021-03-04 Weinhoff Gregory M 958,981.0 A-Award A 958,981.0 5.84 5,600,449.04
2021-02-19 HUSSAIN IQBAL J 333,559.0 A-Award A 333,559.0 0.00 0.00
2021-02-19 Thorell Marella 208,474.0 A-Award A 208,474.0 0.00 0.00
2021-01-29 Thorell Marella 58,956.0 A-Award A 58,956.0 0.00 0.00
2021-01-29 Thorell Marella 9,487.0 A-Award A 9,487.0 0.00 0.00
2021-01-29 De Rubertis Francesco 44,828.0 A-Award A 44,828.0 0.00 0.00

Disclaimer: The data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by our third party API www.financialmodellingprep.com, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore, Discounting Cash Flows Group doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Discounting Cash Flows Group or anyone involved with Discounting Cash Flows Group will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.